Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.23B
Enterprise Value3.03B
P/E Ratio15.13
PEG Ratio0.59
Price/Sales Ratio3.27
Price/Book Ratio1.4
Enterprise/Revenue3.17
Enterprise/EBITDA11.02

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.22
Operating Margin0.26
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.1

Income Statement

Revenue1.04B
Revenue/Share2.05
Gross Profit803.62M
EBITDA281M
Net Income198.12M
Diluted EPS0.39

Balance Sheet

Total Cash570.93M
Total Cash/Share1.13
Total Debt50.98M
Total Debt/Equity0.02
Current Ratio4.8
Book Value Per Share4.81

Price History

52-Week Change-6.01
52-Week High8.6
52-Week Low5.32
Moving Average 50 Days6.35
Moving Average 200 Days6.73

Statistics

Average Volume21.21M
Shares Outstanding503.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield4.46
Payout Ratio0.01
Last Split Factor17:10
Last Split DateMay 30, 2019
AD